Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-28

Clinical Trial Update: RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing radiation therapy with or without cetuximab in patients who have undergone surgery for locally advanced head and neck cancer; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERBITUX (cetuximab)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Head and Neck Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-05-28